Head & Neck Cancer Survivorship: Physical and Functional Status

Sponsor
Vanderbilt University (Other)
Overall Status
Completed
CT.gov ID
NCT00751816
Collaborator
National Cancer Institute (NCI) (NIH)
23
3
7
7.7
1.1

Study Details

Study Description

Brief Summary

RATIONALE: Early physical therapy may be effective in improving range of motion of the neck and shoulders in head and neck cancer survivors who are undergoing chemotherapy and radiation therapy.

PURPOSE: This phase I trial is studying how well early physical therapy works in improving physical and functional well-being in head and neck cancer survivors receiving chemoradiotherapy.

Condition or Disease Intervention/Treatment Phase
  • Drug: systemic chemotherapy
  • Other: survey administration
  • Procedure: adjuvant therapy
  • Procedure: management of therapy complications
  • Procedure: musculoskeletal complications management/prevention
  • Procedure: physical therapy
  • Radiation: radiation therapy

Detailed Description

OBJECTIVES:
  • Describe the physical and functional well-being of head and neck cancer (HNC) survivors undergoing physical therapy during adjuvant chemoradiotherapy.

  • Describe clinical measure of range of motion for the cervical spine and shoulder of HNC survivors undergoing physical therapy during adjuvant chemoradiotherapy.

  • Determine the feasibility of an early physical therapy intervention (prior to and during adjuvant treatment) targeting the physical needs of HNC survivors.

OUTLINE: Patients undergo physical therapy weekly for 10 weeks beginning 1 week prior to initiating adjuvant chemoradiotherapy and continuing until 2 weeks after the completion of adjuvant chemoradiotherapy.

Patients undergo range of motion assessment and complete a Cancer Survivorship Survey (CSS) at baseline and in weeks 4, 8, 9, and 10 of physical therapy.

Study Design

Study Type:
Observational
Actual Enrollment :
23 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Head & Neck Cancer Survivorship: Physical and Functional Status
Study Start Date :
Jun 1, 2008
Actual Primary Completion Date :
Jan 1, 2009
Actual Study Completion Date :
Jan 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Supportive Care

head and neck cancer survivors who are undergoing chemotherapy and radiation therapy

Drug: systemic chemotherapy
Other Names:
  • none noted
  • Other: survey administration
    will be administered before, during, and after medical intent-to-cure treatment to describe head and neck cancer survivors' physical and functional well-being.
    Other Names:
  • none noted
  • Procedure: adjuvant therapy
    Other Names:
  • none noted
  • Procedure: management of therapy complications
    Other Names:
  • None noted
  • Procedure: musculoskeletal complications management/prevention
    Other Names:
  • none noted
  • Procedure: physical therapy
    weekly visits coordinated with adjuvant treatment as part of standard care
    Other Names:
  • none noted
  • Radiation: radiation therapy
    Other Names:
  • none noted
  • Outcome Measures

    Primary Outcome Measures

    1. Physical and functional well-being during adjuvant chemoradiotherapy [2 weeks after completing treatment]

    2. Range of motion for the cervical spine and shoulder during adjuvant chemoradiotherapy [2 weeks after completing treatment]

    3. Feasibility of an early physical therapy intervention [2 weeks after completing treatment]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    DISEASE CHARACTERISTICS:
    • Head and neck cancer survivor

    • Planning to receive adjuvant chemoradiotherapy for head and neck cancer

    • Has not yet initiated adjuvant therapy

    • Referred to rehabilitation oncology physical therapy program

    Exclusion Criteria:
    • No metastatic disease

    • No CNS cancer

    PATIENT CHARACTERISTICS:
    • Speaks English

    • No significant history of cardiovascular or neurovascular disease involving disability

    PRIOR CONCURRENT THERAPY:
    • See Disease Characteristics

    • Not currently in hospice care

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Vanderbilt-Ingram Cancer Center - Cool Springs Nashville Tennessee United States 37064
    2 Vanderbilt-Ingram Cancer Center at Franklin Nashville Tennessee United States 37064
    3 Vanderbilt-Ingram Cancer Center Nashville Tennessee United States 37232-6838

    Sponsors and Collaborators

    • Vanderbilt University
    • National Cancer Institute (NCI)

    Investigators

    • Study Chair: Ann Marie Flores, Ph.D., Vanderbilt-Ingram Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Vanderbilt University
    ClinicalTrials.gov Identifier:
    NCT00751816
    Other Study ID Numbers:
    • CDR0000613863
    • VU-VICC-SUPP-0843
    First Posted:
    Sep 12, 2008
    Last Update Posted:
    Dec 10, 2015
    Last Verified:
    Dec 1, 2015
    Keywords provided by Vanderbilt University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 10, 2015